Cricket Canada Confronts Crisis Amidst Crime and Corruption Allegations
Organized Crime Casts a Dark Shadow Over Canadian Cricket
the canadian cricket community is grappling with unprecedented...
Image Credits:TechCrunch / TechCrunch 12:50 PM PDT · April 16, 2026 For a successful deep tech startup, the laboratory breakthrough is only the first step. To spin out an innovative technology into a scalable business, a founder has to navigate a complicated legal process. This week on Build Mode, Isabelle Johannessen speaks with Capella Kerst
Science Corporation, the startup from former Neuralink president and co-founder Max Hodak, has enlisted a top neurobiologist to lead the first U.S. human trials for its biohybrid brain-computer interface. Dr. Murat Günel, chair of Yale Medical School’s Department of Neurosurgery, has signed on as a scientific adviser after two years of discussions. His goal is
Fusion power startup Inertia Enterprises said on Tuesday that it has signed three agreements with the Lawrence Livermore National Laboratory (LLNL) to help bring the laser-based fusion reactor pioneered at the Californian lab to market. The deals could give Inertia a boost over rival startups. The National Ignition Facility (NIF) at LLNL is so far
For all the hype about data centers in space, there just aren’t very many GPUs up there. As that starts to change, the near-term business of orbital compute is starting to take shape. The largest compute cluster currently in orbit was launched by Canada’s Kepler Communications in January, and boasts about 40 Nvidia Orin edge
After 10 days, the four astronauts aboard the Orion spacecraft have returned to Earth, their mission around the Moon a success. Integrity, the name of the crew’s spacecraft as part of NASA’s Artemis II mission, splashed down in the Pacific Ocean off the coast of San Diego, California, at 5:07 p.m. Pacific Time, according to
Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency. Schwartz, who will have to be confirmed by the
Pancreatic cancer, illustration Nemes Laszl | Science Photo Library | Getty Images Revolution Medicines ' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of survival and slashing the risk of death by 60% versus chemotherapy, the company said Monday. RevMed said its daily pill, daraxonrasib, met
We use cookies to measure marketing efforts and improve our services. Please review the cookie settings and confirm your choice.